Part I — Situation overview

Within a few days three interrelated healthcare turns took place. The Obstetrics-Gynaecology Section of the Healthcare Professional College proposed in a letter to Health Minister Zsolt Hegedűs the repeal of the contested heartbeat decree — the regulation that made the procedure conditional, before an abortion, on listening to the foetal heartbeat. The letter quoted by HVG is unambiguous:

„A nők abortuszra vonatkozó döntéseit tiszteletben kell tartani, így azt befolyásoló, korlátozó jogszabályra nincs szükség."

In parallel, according to 444.hu’s report, epidemiologist (epidemic expert) Beatrix Oroszi became the new chief medical officer, while according to Telex and Portfolio the National Health Insurance Fund (OEP — the state administrator of social-insurance health insurance) is taking over from the Batthyány-Strattmann László Foundation the main tasks of adjudicating life-saving, individual medicine requests; according to Portfolio the change takes effect from September. According to Telex’s report, the minister consulted both the foundation’s representatives and the OEP’s future director-general before the decision.

The common denominator of the three strands is the relationship of professional and political decision-making. The heartbeat-decree debate is about whether a professionally contested, by many accounts politically motivated regulation should be withdrawn on the proposal of the professional body. The chief medical officer’s appointment is about the professionalisation of public-health leadership. And the reorganisation of individual medicine requests touches the financing institutional system of life-saving care — who decides, and in what procedure, on supporting a patient’s life-saving treatment. In MIAK’s reading all three pose the same question: how can it be guaranteed that healthcare decisions are driven by evidence and professionalism, not by day-to-day politics. (The institutional details of the chief medical officer’s appointment were treated separately in an earlier MIAK analysis of 2 June 2026; this post focuses on three fresh events in the relationship of professionalism and politics.)

Part II — Literature foundation

Before turning to MIAK’s proposals, it is worth fixing the scientific frame. The literature of European health governance — the volumes of the European Observatory on Health Systems and Policies (the joint EU–WHO health-policy research network) — describes with the concept of depoliticisation the process in which risk-assessment and professional decisions are placed with scientific bodies independent of political deliberation, in order to increase the credibility of the decision. According to the Health Systems Governance in Europe volume, the aim of evaluation entrusted to scientific committees is precisely to strengthen the credibility of professional decision-making — but the volume also warns: the ‘politicisation of science’ works in reverse too, if politics intervenes in the work of the professional body. The 2025 State of Health in the EU report adds to this the strengthening of prevention and the reform of affordable, sustainable access to medicines as a common reform direction of member-state health systems. From these two sources MIAK’s frame follows: restoring professional bodies to the decision chain is right, but only lasting if institutional-legal guarantees protect it from political backlash. The detailed literature treatment can be found in section 6.4 Literature in detail.

Part III — MIAK’s concrete proposal

MIAK proposes three measurable measures that build professionalism not on a single good decision but on lasting institutional guarantees.

The withdrawal of the heartbeat decree is a correct step, but according to MIAK the lesson is broader: the withdrawal of risky, evidence-lacking regulations should not be left to the goodwill of the minister of the day. MIAK proposes that the making and withdrawal of healthcare-related legislation be linked to mandatory, public professional-body opinion — in line with the I3 legislative impact assessment programme point, which prescribes a mandatory, public impact assessment for every new rule. Thus the professional body’s say is retained even when the given decision is politically uncomfortable.

3.2 A transparent, predictable individual medicine-request procedure at the OEP (for the September transition)

The move of individual medicine requests from the foundation to the OEP is an opportunity to make the procedure more predictable — but also a risk if, during the transition, patients’ cases get stuck. In line with the E5 patient-decision support and the E3 waiting-list transparency programme points, MIAK proposes that the new system operate with fixed adjudication deadlines, public anonymised statistics (how many requests, what turnaround time, what acceptance rate) and clear, frequency-format patient information. Until the September entry into force, a transitional guarantee is needed so that no single ongoing life-saving request falls through because of the reorganisation.

3.3 A prevention data programme with a professional mandate for public-health leadership

The professionalisation of public-health leadership fulfils its purpose if it comes with a genuine professional mandate. In line with the E4 prevention data programme, MIAK proposes that the national chief-medical-officer organisation be empowered to analyse public-health data and to run targeted prevention campaigns in the most affected regions — in line with the main direction of the 2025 State of Health in the EU report, which sets out the strengthening of the prevention of non-communicable diseases. The professional leader’s mandate should rest not on a good relationship with the minister but on a fixed competence.

The common principle of the three proposals is that they institutionalise professionalism: the legal codification of the right of opinion, the transparent medicine-request procedure and the prevention mandate together ensure that the present correct decisions are the result not of one-off goodwill but of a lasting system.

Part IV — Expected impacts and risks

Dimension Expected impact Risk
Healthcare The weight of professional bodies grows, evidence-based regulation Professionalism may recede if it depends only on the will of a single minister
Society Respect for the decision affecting women; more predictable patient care During the reorganisation, life-saving requests may get stuck
Public administration Professionalised public-health leadership, a transparent medicines system The capacity and transition risk of a new institutional party (OEP)

The main dilemma is whether the autonomy of professional decision becomes institutionalised or remains person-dependent. The proposal works if the right of opinion and the prevention mandate are fixed by law. It tips to the risk side if the practical details of the reorganisation (the OEP’s takeover capacity, the guarantees of the transition period) remain undeveloped — then the correct direction in principle may be realised at the expense of patients. The September deadline calls for realistic planning, not haste.

Part V — Measurability and summary

5.1 What is worth tracking? (suggested KPIs)

MIAK considers the following suggested performance indicators (KPIs) worth tracking:

  • Professional-opinion ratio: what percentage of healthcare legislation had a mandatory, public professional-body opinion attached.
  • Medicine-request turnaround time: the average time and acceptance rate of adjudicating individual medicine requests before and after the OEP takeover — the aim is a shortening, predictable turnaround.
  • Prevention coverage: the share of the most affected regions reached by targeted public-health prevention programmes.

5.2 Summary

MIAK’s message is that the return of professionalism to healthcare is welcome, but only lasting if it becomes institutionalised: let a law fix the professional bodies’ right of opinion, the transparent procedure for individual medicine requests, and the prevention mandate of public-health leadership. From the ministerial decision-makers MIAK requests these three guarantees — with a concrete transitional safety net for the September medicines transition. The topic moves two MIAK foundational values: data-drivenness, because healthcare regulation must rest on evidence and public-health data, not on political consideration; and universal representation, because respecting the decision affecting women and fair, predictable access to life-saving treatment are the fundamental interest of every patient — regardless of which region they live in or how much they earn.

Part VI — Justifications and further sources

6.1 Press framing by spectrum

The left-liberal and public-affairs band highlighted the professional body’s position and the patient side: HVG quoted the Obstetrics-Gynaecology Section’s letter (respect for women’s decision), Telex the institutional details of the OEP takeover, 444.hu the professional background of the chief-medical-officer appointment (‘an epidemic expert got the post’). The economic band (Portfolio) framed the financing-timing aspect (the fate of support for life-saving treatments, the September entry into force), and 24.hu the fact of the reorganisation. ATV recorded the sharp, ’turned to shouting’ nature of the parliamentary debate — signalling that the heartbeat decree is politically divisive too. The pro-government/conservative band approached more cautiously: Magyar Nemzet gave a questioning, wait-and-see framing under the title ‘A new chief medical officer, a new approach?’, querying the professional grounding of the changes. For MIAK the lesson is that the topic can be handled calmly if the debate is driven by professional evidence, not by political camp-logic.

6.2 Facts and data

  • Heartbeat decree: the Obstetrics-Gynaecology Section of the Healthcare Professional College proposed the repeal in a letter to Minister Zsolt Hegedűs (HVG, 2 June 2026).
  • Chief medical officer: epidemiologist Beatrix Oroszi became the new chief medical officer (444.hu, 2 June 2026).
  • Individual medicine requests: the OEP is taking over the main tasks of the Batthyány-Strattmann László Foundation; according to Portfolio the change takes effect from September (Telex, Portfolio, 24.hu, 2 June 2026).
  • European context: according to the 2025 State of Health in the EU report, the common reform direction of member states is the strengthening of prevention and affordable access to medicines (source: European Commission / OECD, State of Health in the EU 2025).

6.3 Policy aspects

  • Healthcare (programme points) — prevention data programme, patient-decision support, waiting-list transparency;
  • Social policy (background material) — fair, predictable access to life-saving care as a question of social security;
  • Justice (programme points) — the mandatory, public legislative impact assessment as a guarantee of professional opinion.

6.4 Literature in detail

6.4.1 European Observatory on Health Systems and Policies: Health Systems Governance in Europe

The volume describes depoliticisation as one of the recurring mechanisms of European health governance: handing over risk assessment and professional decision to independent, scientific bodies so that the credibility of the decision grows. According to the authors, the aim of evaluation entrusted to a scientific committee is precisely ’the promotion of the credibility of scientific decision-making’ — yet the volume warns of the reverse process too: science can become ‘politicised’ if politics intervenes directly in the work of the professional body. In the case of the heartbeat decree this means that withdrawal on the proposal of the professional body is the right direction — but the lesson is the guarantee: professional opinion must be institutionalised, otherwise in the next cycle politics may again override the profession.

📖 Source: European Observatory on Health Systems and Policies: Health Systems Governance in Europe

6.4.2 European Commission / OECD: State of Health in the EU — 2025 Synthesis Report

The report fixes the common reform direction of member-state health systems in four areas, two of which connect directly to the Hungarian developments: the strengthening of the prevention of non-communicable diseases and affordable, sustainable access to medicines. According to the report, member states ‘strengthen primary prevention through firmer public-health policies’ and ‘redesign pharmaceutical policy to improve affordability and sustainability’. The Hungarian individual medicine-request reorganisation and the preventive chief-medical-officer mandate fit into this common European direction — provided that transparency and patient-rights guarantees are also realised.

📖 Source: European Commission / OECD: State of Health in the EU — 2025 Synthesis Report

6.5 International comparison

In European practice the decision-making role of professional-scientific bodies is institutionally protected: medicine evaluation and risk assessment are typically placed with independent professional agencies, and national health regulation is in ever more places tied to mandatory, public impact assessment. The reform of affordable access to medicines — within the frame of the 2025 State of Health in the EU — is realised in several member states through making the financing institution more transparent and predictable. The lesson for the Hungarian reorganisation: the institutional form (foundation or OEP) matters less than the transparency of the procedure and the existence of patient-rights guarantees.

Healthcare

  • E3 — Waiting-list transparency
  • E4 — Prevention data programme
  • E5 — Patient-decision support

Justice

  • I3 — Legislative impact assessment

Proposed new programme point: Mandatory, public right of opinion for professional bodies in healthcare legislation — for the Healthcare area.

6.7 Source register

Press sources (MIAK press monitor, 3 June 2026 — topic 3):

Knowledge-base references (literature):

  • 📖 European Observatory on Health Systems and Policies: Health Systems Governance in Europe
  • 📖 European Commission / OECD: State of Health in the EU — 2025 Synthesis Report

Note: the sources’ local file path does not appear in the visible text of the blog — only the publisher/author and the title.

MIAK internal materials:

  • MIAK policy area: Healthcare (programme points; programme point ID: E3, E4, E5)
  • MIAK policy area: Justice (programme points; programme point ID: I3)
  • MIAK press monitor, 3 June 2026 — topic 3, score: 90/100

Additional public data sources:

  • WHO European Health Report 2024; OECD Health at a Glance: Europe 2024 — public-health and care indicators

Generation metadata